Anna leads the Strategy & Corporate Finance Practice for Switzerland and coleads M&A strategy and portfolio for the Life Sciences Practice around the world. She is a globally recognized merger management and carve-out advisor specializing in advising boards and management teams in designing, planning, and executing complex, cross-border integrations, separations, and alliances. She also helps her clients develop M&A blueprint and build M&A capabilities.
Anna has close to twenty years of M&A experience, advising clients in buying and selling across the entire M&A value chain. She has supported more than 110 M&A deals, ranging from $200 million to $50 billion. While her industry focus is on life sciences, she has worked across multiple industries, ranging from consumer and industrials to technology.
Anna also has extensive consulting, corporate, and private-equity experience. She regularly lectures on M&A topics at business schools across Europe and has authored numerous studies.
In addition to her work with M&A, she is also passionate about diversity and has served in multiple roles and boards to further diversity and inclusion.
Anna has previously held various executive management roles including being the Chief People Officer for Deloitte in Switzerland.
EXPERTISE
M&A, Life Sciences, Private Equity & Principal Investors, Strategy & Corporate Finance, Carve-outs, Merger Management
PAST EXPERIENCE
Deloitte – Partner, Managing partner, Director
Gyrus Capital – Operating-advisory partner
Advance – Vice president of the board
EDUCATION
University of Gothenburg – MS and BA, Business Administration and Economics
